Rethinking Youth Gender Medicine with Dr Louise Irvine
Dr Louise Irvine, GP and Co-Chair of the Clinical Advisory Network on Sex and Gender, joins the Beyond Gender hosts for a searching conversation about how British healthcare institutions lost their clinical footing — and what a course correction might look like. From the WellBN investigation to the evidence on puberty blockers, this episode asks the hard questions that too few medical bodies have been willing to put on the table.
Dr Louise Irvine has spent years working at the intersection of general practice and gender medicine, and she brings to this episode something rare in public debate: the perspective of a clinician who has watched, from close range, how the medical establishment lost its way. As Co-Chair of the Clinical Advisory Network on Sex and Gender, she is part of a growing effort to rebuild rigour — not through ideology, but through evidence, ethics and honest conversation. It is exactly the kind of voice Stella, Mia and Bret have built Beyond Gender to platform. A significant portion of the conversation centres on CAN-SG's London conference, Rethinking Youth Gender Medicine, taking place on 5th and 6th July. Rather than relitigating controversies already well covered elsewhere, Irvine frames it as a genuine attempt to synthesise what has been learned about aetiology, clinical practice and what good care for distressed young people actually looks like. For listeners who have followed this debate but found it heavy on conflict and light on constructive alternatives, that framing is a welcome shift. The WellBN clinic features prominently, and Irvine offers a careful account of what the recent investigation revealed. Her analysis of institutional capture — how organisations as embedded and trusted as the NHS came to adopt a model of care that bypassed the usual standards of evidence — is measured and precise. She is not interested in assigning blame so much as in understanding the mechanisms: how good intentions, ideological pressure and the suppression of clinical dissent combined to produce harm on a scale that is only now being fully reckoned with. The discussion of puberty blockers is particularly valuable. Irvine engages with the concept of Tooth Fairy Science — the idea that an intervention can become entrenched in clinical settings before any real evidence base exists — and applies it directly to the blocker trial. The hosts press her on what genuinely rigorous research into gender-related distress would need to look like, and who has the standing and independence to conduct it. It is one of the more substantive exchanges on this specific question the podcast has hosted. There is also time for a more hopeful thread: what psychotherapy offers young people experiencing gender dysphoria, and the data linkage work researchers hope will finally allow proper longitudinal follow-up on outcomes. Irvine speaks with the authority of someone who believes clinical good sense is recoverable, and that the conference represents one concrete step toward recovering it. The conversation is unhurried, the guest is authoritative, and the hosts bring their usual combination of intellectual rigour and genuine concern for the young people at the centre of this debate.
Watch and subscribe on YouTube
Open this episode on the Beyond Gender channel
